v3 Template
E

Enigma Biomedical USA

Healthcare / Biotechnology ~240 employees
Founded
--
Employees (Est.)
~240
12 leaders known
Total Funding
$2.0M
Funding Rounds
1
Last Funding
2025-11-25

About Enigma Biomedical USA

Enigma Biomedical Group aims to be the premier provider of information and technology to researchers and clinicians to improve brain health. Their mission is to provide broad access to biomarkers of neurological pathologies and essential tools and information technology to accelerate the development and approval of effective therapies for Alzheimer's and other neurodegenerative diseases.

Products & Services

PET Tracers for Neurological Disorders:A pipeline of high-impact PET tracers focusing on non-AD 4R Tauopathies for imaging Tau pathology in conditions like Progressive Supranuclear Palsy (PSP), Corticobasal syndrome (CBS), and Familial frontal temporal dementias (fFTDs).
Muscarinic Acetylcholine Receptor M4 Ligand [11C]MK-6884:A tracer useful for measuring cholinergic tone alteration in Alzheimer's disease (AD) patients.
MK-6240 Tau Imaging Agent:A novel PET tracer for imaging neurofibrillary tangles in Alzheimer's disease, used to enhance decision-making in drug development and clinical practice.

Specialties

Neurological Biomarkers PET Imaging for Neurodegenerative Diseases Tau Imaging Agents Alzheimer's Disease Research Partnership Network Development Technology Transfer for Production Networks Quality and Regulatory Affairs Data Management

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Grant
T: -
FT: Grant
A: 2000000
MR: -
FA: $2 million
FAN: 2000000
D: 2025-11-25
FD: 2025-11-25
1 investors
Grant Latest
2025-11-25
$2.0M
1 investor (Pro only)

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

R

Rick Hiatt

Board Chairman & CEO

D

Dr. Samantha Budd Haeberlein

Chief Medical Officer

H

Hartmuth C. Kolb

Chief Science Officer

S

Serge Gauthier

Chairman of the Scientific Advisory Board

D

Dr. Eric Reiman

CEO, Banner Alzheimer's Institutes

K

Keith Johnson M.D., Ph.D.

Professor of Radiology and Neurology

View 9 more team members with Pro

Unlock Full Team Directory

Recent News

Enigma Biomedical USA Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Healthcare / Biotechnology
Company Size
~240 employees (est.)

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro